TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198.

Trachtman H, Kretzler M, Gesualdo L, Cross N, Workeneh B, Kaufeld J, Meijers B, Ye Z, Chen Q, Derebail VK, Ng MSY, Ji B, Lobmeyer MT, Retlich S, Licarião Rocha FT, Prasad S, Soleymanlou N

Open source

DOI: 10.1016/s0140-6736(25)02255-x
Published: 2026 Feb 7
Container: Lancet (London, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-25-02255-x,
  title = {TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198.},
  author = {Trachtman H and Kretzler M and Gesualdo L and Cross N and Workeneh B and Kaufeld J and Meijers B and Ye Z and Chen Q and Derebail VK and Ng MSY and Ji B and Lobmeyer MT and Retlich S and Licarião Rocha FT and Prasad S and Soleymanlou N},
  year = {2026},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(25)02255-x},
  url = {https://doi.org/10.1016/s0140-6736(25)02255-x}
}

RIS

TY  - JOUR
TI  - TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198.
AU  - Trachtman H
AU  - Kretzler M
AU  - Gesualdo L
AU  - Cross N
AU  - Workeneh B
AU  - Kaufeld J
AU  - Meijers B
AU  - Ye Z
AU  - Chen Q
AU  - Derebail VK
AU  - Ng MSY
AU  - Ji B
AU  - Lobmeyer MT
AU  - Retlich S
AU  - Licarião Rocha FT
AU  - Prasad S
AU  - Soleymanlou N
PY  - 2026
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(25)02255-x
UR  - https://doi.org/10.1016/s0140-6736(25)02255-x
ER  -

APA

H, T., M, K., L, G., N, C., B, W., J, K., B, M., Z, Y., Q, C., VK, D., MSY, N., B, J., MT, L., S, R., FT, L. R., S, P., & N, S. (2026). TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(25)02255-x

Source records

pubmed · retrieved 2026-09-26T22:48:34.573Z